Waldenström makroglobulinemili bir hastada mandibuler inatçı enfeksiyon olgusu

Waldenström Makroglobulinemisi WM , farklılaşmış terminal B lenfositlerin neoplastik klonal proliferasyonuyla, aşırı IgM üretimiyle karakterize nadir görülen bir hastalıktır. Bu hastalık, monoklonal IgM proteiniyle karakterize lenfoplasmositik lenfomadır. Osteomiyelit ise; bir mikroorganizmanın infeksiyöz ve inflamatuar süreçler ile kemik dokuda hasar yaratması sonucu ortaya çıkan ilerleyici karakterde bir hastalıktır. Kemiğin sadece bir bölümü tutulabildiği gibi, medüller kanal, periost, korteks, ve çevre yumuşak dokuların tümü bu tabloya katılabilir. WM’li hastalarda muskuloskeletal enfeksiyonlar nadir görülür. Literatürde septik artrit vaka raporları oldukça nadirdir ve yayınlarda sadece bir bölgede lumbar vertebral bölgede osteomiyelit görülmüştür. Biz de bu çalışmada; WM’li bir hastada mandibulada gelişen inatçı enfeksiyon tablosunu, alınan kültürden edinilen bilgilerin ışığında, enfeksiyon kaynağı olan dişlerin çekimi, antibiyoterapi, anti-inflamatuar ilaçların kullandırılması ve hiperbarik oksijen tedavisi uygulaması ile değerlendirdik. 7. Ay sonundaki panoromik filme göre kemik dokuda iyileşmenin olduğu görülmüştür. Hastanın şikayetleri sona ermiş ve olumlu sonuçlar alınmıştır

A case of stubborness infection in mandibula, in a patient with Waldenström Macroglobulinemia

Waldenström Macroglobulinemia WM is a rare disorder characterized by excessive IgM production resulting from neoplastic clonal proliferation of differentiated terminal B lymphocytes. This disorder is a lymphoplasmocytic lymphoma characterized by monoclonal IgM protein. Osteomyelitis is a progressive disease characterized by destruction of bone tissue by a microorganism through infectious and inflammatory processes. It may involve only a part of the bone although medullary canal, periosteum, cortex, and adjacent soft tissues may all be involved by the disease process. Musculoskeletal infections are rare in patients with WM. The septic arthritis cases in the previous literature are quite sparse and in studies osteomyelitis was observed at only one area at lumbal vertabral area. In this study we assessed a stubborness infection process in a patient with WM by treating her by extraction of the infectious teeth, antibiotherapy, anti-inflammatory agents, and hyperbaric oxygen therapy in the light of culture results. An improvement in panoramic film was observed after 7 months. The patient was free of her complaints, and a favorable outcome was achieved

___

  • Fauci AS,Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harison’s principles of internal med- icine. 17th ed. New York: McGraw-Hill Medi- cal; 2008.
  • Waldenström J. Macroglobulinemia. Acta Haematol 1958;20:33-39
  • Vitolo U, Ferreri AJ, Montoto S. Lym- phoplasmacytic lymphoma- Waldenström’s Macrogloblunemia . Crit rev Oncol Hematol 2008;67:172-185
  • Pangalis GA, Angelopoulou MK, Vas- silakopoulos TP, et al. B-chronic lymphocytic leukemia,small lymphocytic lymphoma, and lymphoplasmacytic lymphoma,including Wal- denström’s macroglobulinemia: A lini- cal,morphologic, and biologic specturum of similar disorders. Semin Hematol 1999;36:104-114
  • Taylor PW, Fischbein LC. Septic arth- ritis in Waldenström’s macroglobulinemia. J Rheumatol. 1994;21:776-7.
  • Singwe-Ngandeu M, Buchs N, Rohner P, Gabay C. Waldenström’s disease compli- cated by recurrent meningococcal arthritis. J Clin Microbiol.2001;39:3013-4.
  • Apisarnthanarak A,Razavi B,Bailey T. Disseminated Nocardia asteroides presenting as pulmonary non-caseating granulomas in a patient with Waldenström macroglobuline- mia.Infection.2002;30:38-40.
  • Lazzarini L, Mader JT, Calhoun JH: Osteomyelitis in long bones. J Bone Joint Surg 2004, 86-A(10):2305-18.
  • Mader JT: Animal models of osteo- miyelitis. Am J Med 1985,78(suppl 6B):213-7.
  • Lew DP, Waldvogel FA: Osteomiyeli- tis. N Engl J Med 1997,336(14):999-1007.
  • Evans RP, Nelson CL, Lange TA: Pa- thophysiology of Osteomyelitis. In: Surgery of the musculoskeletal system, McCollister Ewarts (ed), Churchill Livingstone, 1990, s:19- 35.
  • Nair SP, Meghji S, Wilson M, Reddi K, White P, Henderson B:Bacterially induced bone destruction: mechanisms and misconcep- tions.Infect Immun 1996, 64(7):2371-80.
  • Millar SJ, Goldstein EG, Levine MJ, Hausmann E:Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis.Infect Immun 1986, 51(1):302-6.
  • Riancho JA, Salas E, Zarrabeitia MT, Olmos JM, Amado JA,Fernandez-Luna JL, Gonzalez-Macias J: Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Miner Res 1995, 10(3):439-46.
  • Ishihara Y, Nishihara T, Maki E, No- guchi T, Koga T: Role of interleukin-1 and prostaglandin in vitro bone resorption induced by Actinobacillus actinomycetemcomitans li- popolysaccharide. J Periodontal Res 1991, 26(3 Pt 1):155-60.
  • Franchi-Miller C, Saffar JL: The 5- lipoxygenase inhibitor BWA4C impairs os- teoclastic resorption in a synchronized model of bone remodeling. Bone 1995, 17(2):185-91.
  • Lew DP, Waldvogel FA: Osteomyeli- tis. Lancet 2004,364(9431):369-79.
  • Wang J, Li F, Calhoun JH, Mader JT: The role and effectiveness of adjunctive hyperbaric oxygen therapy in the management of musculoskeletal disorders. J Postgrad Med 2002,48(3):226-31.